欣賀股份(003016.SZ):擬1億元成立全資子公司欣賀騰盈
格隆匯10月15日丨欣賀股份(003016.SZ)公佈,公司於2024年10月15日召開第五屆董事會第四次會議,審議通過了《關於對外投資成立全資子公司的議案》。公司為了拓展創新業務,響應政府政策進行戰略性投資,提高公司核心競爭力,進一步提升公司整體盈利能力,公司以自有資金投資1億元成立全資子公司欣賀騰盈投資有限公司(最終以工商登記機關核准登記名稱為準),投資範圍擬主要圍繞低空經濟(包括民用有人駕駛、無人駕駛航空器以及載人、載貨等多場景低空飛行活動)、人工智能、新型科技等科技創新產業。公司後續將根據實際投資項目,審慎評估和論證,逐步進行投資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.